Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trialJonathan Gelfond, Michael A. Liss, Dharam Kaushik et al.|Urologic Oncology Seminars and Original Investigations|2018Cited by 20
Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinomaAashish Kabra, Michael A. Liss, Jonathan Gelfond|European Journal of Cancer Prevention|2017Cited by 4